These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34383842)

  • 1. Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a "non-COVID" hospital in Mexico City.
    Cruz-Arenas E; Cabrera-Ruiz E; Laguna-Barcenas S; Colin-Castro CA; Chavez T; Franco-Cendejas R; Ibarra C; Perez-Orive J
    PLoS One; 2021; 16(8):e0255916. PubMed ID: 34383842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
    BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City.
    Dávila-Conn V; Soto-Nava M; Caro-Vega YN; Paz-Juárez HE; García-Esparza P; Tapia-Trejo D; Pérez-García M; Belaunzarán-Zamudio PF; Reyes-Terán G; Sierra-Madero JG; Galindo-Fraga A; Ávila-Ríos S
    PLoS One; 2022; 17(3):e0264964. PubMed ID: 35298500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of anti-SARS-CoV-2 antibodies and associated factors in healthcare workers of a Mexican Covid-19 hospital.
    Herrera-Ortiz A; Rojas-Delgado HU; García-Cisneros S; Xibille-Friedmann DX; Martínez-Barnetche J; Olamendi-Portugal M; González-Sánchez HM; Sánchez-Alemán MÁ
    Salud Publica Mex; 2022 Jul; 64(4, jul-ago):348-356. PubMed ID: 36130357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Burden of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Mexico City: A Data-Driven Call to Action.
    Antonio-Villa NE; Bello-Chavolla OY; Vargas-Vázquez A; Fermín-Martínez CA; Márquez-Salinas A; Pisanty-Alatorre J; Bahena-López JP
    Clin Infect Dis; 2021 Jul; 73(1):e191-e198. PubMed ID: 32986819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
    Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
    Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy.
    Scozzari G; Costa C; Migliore E; Coggiola M; Ciccone G; Savio L; Scarmozzino A; Pira E; Cassoni P; Galassi C; Cavallo R; The Collaborative Group
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Mortality of Health-Care Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Mexico City.
    Guerrero-Torres L; Caro-Vega Y; Crabtree-Ramírez B; Sierra-Madero JG
    Clin Infect Dis; 2021 Jul; 73(1):e199-e205. PubMed ID: 32986118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe.
    Rusakaniko S; Sibanda EN; Mduluza T; Tagwireyi P; Dhlamini Z; Ndhlovu CE; Chandiwana P; Chiwambutsa S; Lim RM; Scott F; Sibanda LM; Mutapi F
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009254. PubMed ID: 33788840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of antibody responses after SARS-COV-2 infection in healthcare workers in the first wave of COVID-19 pandemic in Mexico City.
    Thompson-Bonilla MDR; León JA; Cárdenas-Turrent MB; Peña-Thompson A; Hanessian-De la Garza D; Zavala-Vega S; Xicohtencatl-Cortes J; Ochoa SA; Cruz-Córdova A; Arellano-Galindo J
    J Int Med Res; 2022 Jul; 50(7):3000605221099458. PubMed ID: 35879824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence.
    Cordioli M; Mirandola M; Gios L; Gaspari S; Carelli M; Lotti V; Sandri A; Vicentini C; Gibellini D; Carrara E; Tacconelli E;
    Epidemiol Infect; 2022 Feb; 150():e48. PubMed ID: 35184764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico.
    Basto-Abreu A; Carnalla M; Torres-Ibarra L; Romero-Martínez M; Martínez-Barnetche J; López-Martínez I; Aparicio-Antonio R; Shamah-Levy T; Alpuche-Aranda C; Rivera JA; Barrientos-Gutierrez T;
    Nat Commun; 2022 Feb; 13(1):589. PubMed ID: 35105873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
    Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
    Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
    Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
    Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.